CORONA, Calif., April 23, 2018 -- Acology Inc. (OTC:ACOL) is pleased to announce the purchase of the entire intellectual property portfolio for their signature product, the MedTainer™. The purchase includes both the U.S. design and utility patents, patents-pending in the European Union, international trademarks, domain names and all manufacturing processes and licenses, including molds, casts, patterns and forms. These properties, previously held by Polymation LLC, will enable the company to move forward with Acology’s plan to expand its growing operation and enable it to begin developing new products based on the unique engineering principles that have made the MedTainer so successful. Acology’s public portfolio also expands considerably with this acquisition.
The acquisition of the intellectual property catalog took nearly a year to negotiate with final execution of the agreement April 14, 2018.
“It’s most gratifying to say the least, to complete an acquisition that provides such significant benefit to the Company and our shareholders,” says Acology CEO, Curt Fairbrother. “This acquisition is consistent with our aggressive expansion into the Californian and Canadian markets where beneficial legislation may soon pass. Armed with this expansive Intellectual Property portfolio, we can now begin to really concentrate on penetration into markets that we have identified as underserved.”
“We believe we have an indispensable product for not one, but two, rapidly expanding industries in the rapidly growing legal marijuana marketplace,” added Acology’s Chief Operating Officer, Doug Heldoorn. “Our intention has always been to become a truly global enterprise and I believe this purchase is a significant catalyst to that objective.”
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC via the stock symbol “ACOL.” The company’s websites are www.Acologyinc.com for the hospice and palliative care industry, and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to [email protected] or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.


GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems 



